Edition:
United States

TherapeuticsMD Inc (TXMD.A)

TXMD.A on American Stock Exchange

6.80USD
27 Mar 2017
Change (% chg)

$0.03 (+0.44%)
Prev Close
$6.77
Open
$6.65
Day's High
$7.10
Day's Low
$6.59
Volume
157,403
Avg. Vol
246,098
52-wk High
$9.28
52-wk Low
$4.39

TXMD.A

Chart for TXMD.A

About

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials... (more)

Overall

Beta: 1.01
Market Cap(Mil.): $1,337.24
Shares Outstanding(Mil.): 197.52
Dividend: --
Yield (%): --

Financials

  TXMD.A Industry Sector
P/E (TTM): -- 29.17 29.94
EPS (TTM): -0.46 -- --
ROI: -94.33 13.48 13.01
ROE: -94.33 14.39 14.16

BRIEF-Therapeuticsmd reports Q4 loss per share $0.12

* TherapeuticsMD announces fourth quarter and full-year 2016 financial results

Feb 23 2017

BRIEF-Franklin Resources reports 5.7 pct passive stake in TherapeuticsMD as of Dec. 31, 2016 - SEC filing

* Franklin Resources, Inc reports 5.7 percent passive stake in TherapeuticsMD Inc as of Dec. 31, 2016 - SEC filing Source text - (http://bit.ly/2jZSLLl) Further company coverage:

Feb 07 2017

BRIEF-TherapeuticsMD announces Q3 2016 financial results

* TherapeuticsMD announces third quarter 2016 financial results

Nov 03 2016

More From Around the Web

Earnings vs. Estimates